Vestal Point Capital, LP 13D and 13G filings for Astria Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 4:10 pm Sale | 2025-12-31 | 13G | ASTRIA THERAPEUTICS INC ATXS | Vestal Point Capital, LP | 0 0.000% | -4,956,000 (Position Closed) | Filing |
| 2025-11-14 4:02 pm Purchase | 2025-09-30 | 13G | ASTRIA THERAPEUTICS INC ATXS | Vestal Point Capital, LP | 4,956,000 8.800% | 956,000 (+23.90%) | Filing |
| 2024-11-14 12:03 pm Purchase | 2024-09-30 | 13G | ASTRIA THERAPEUTICS INC ATXS | Vestal Point Capital, LP | 4,000,000 7.100% | 4,000,000 (New Position) | Filing |